Read the full article here.
This content was originally published by Rand Organization. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Rand Organization
Our study provides a snapshot of trends in the rate at which opioid therapy was initiated among commercially insured patients during a period of heightened attention to the dangers of opioids and the prominent release of prescribing guidelines by the CDC.